Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer (English)
- New search for: Michels, J.
- New search for: Adam, J.
- New search for: Goubar, A.
- New search for: Obrist, F.
- New search for: Damotte, D.
- New search for: Robin, A.
- New search for: Alifano, M.
- New search for: Vitale, I.
- New search for: Olaussen, K. A.
- New search for: Girard, P.
- New search for: Michels, J.
- New search for: Adam, J.
- New search for: Goubar, A.
- New search for: Obrist, F.
- New search for: Damotte, D.
- New search for: Robin, A.
- New search for: Alifano, M.
- New search for: Vitale, I.
- New search for: Olaussen, K. A.
- New search for: Girard, P.
In:
ANNALS OF ONCOLOGY
;
26
, 12
;
2470-2477
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer
-
Contributors:Michels, J. ( author ) / Adam, J. ( author ) / Goubar, A. ( author ) / Obrist, F. ( author ) / Damotte, D. ( author ) / Robin, A. ( author ) / Alifano, M. ( author ) / Vitale, I. ( author ) / Olaussen, K. A. ( author ) / Girard, P. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 26, 12 ; 2470-2477
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2015-01-01
-
Size:8 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 26, Issue 12
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2361
-
Immunity and HER2-positive disease: never stop questioningLoi, S. et al. | 2015
- 2363
-
Statistical controversies in clinical research: long-term follow-up of clinical trials in cancerCuzick, J. et al. | 2015
- 2367
-
Targeting the undruggable: immunotherapy meets personalized oncology in the genomic eraMartin, S. D. / Coukos, G. / Holt, R. A. / Nelson, B. H. et al. | 2015
- 2375
-
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesNaidoo, J. / Page, D. B. / Li, B. T. / Connell, L. C. / Schindler, K. / Lacouture, M. E. / Postow, M. A. / Wolchok, J. D. et al. | 2015
- 2392
-
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†Kramar, A. / Negrier, S. / Sylvester, R. / Joniau, S. / Mulders, P. / Powles, T. / Bex, A. / Bonnetain, F. / Bossi, A. / Bracarda, S. et al. | 2015
- 2398
-
Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysisIslami, F. / Liu, Y. / Jemal, A. / Zhou, J. / Weiderpass, E. / Colditz, G. / Boffetta, P. / Weiss, M. et al. | 2015
- 2408
-
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesLambertini, M. / Ceppi, M. / Poggio, F. / Peccatori, F. A. / Azim, H. A. / Ugolini, D. / Pronzato, P. / Loibl, S. / Moore, H. C. / Partridge, A. H. et al. | 2015
- 2419
-
Designs of preoperative biomarkers trials in oncology: a systematic review of the literatureMarous, M. / Bièche, I. / Paoletti, X. / Alt, M. / Razak, A. R. / Stathis, A. / Kamal, M. / Le Tourneau, C. et al. | 2015
- 2429
-
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trialBianchini, G. / Pusztai, L. / Pienkowski, T. / Im, Y. H. / Bianchi, G. V. / Tseng, L. M. / Liu, M. C. / Lluch, A. / Galeota, E. / Magazzù, D. et al. | 2015
- 2437
-
A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’ trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRNLeonard, R. C. / Mansi, J. L. / Keerie, C. / Yellowlees, A. / Crawford, S. / Benstead, K. / Matthew, R. / Adamson, D. / Chan, S. / Grieve, R. et al. | 2015
- 2442
-
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trialMunzone, E. / Giobbie-Hurder, A. / Gusterson, B. A. / Mallon, E. / Viale, G. / Thürlimann, B. / Ejlertsen, B. / MacGrogan, G. / Bibeau, F. / Lelkaitis, G. et al. | 2015
- 2450
-
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trialsSunakawa, Y. / Stintzing, S. / Cao, S. / Heinemann, V. / Cremolini, C. / Falcone, A. / Yang, D. / Zhang, W. / Ning, Y. / Stremitzer, S. et al. | 2015
- 2457
-
Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinomaKang, Y. K. / Yau, T. / Park, J. W. / Lim, H. Y. / Lee, T. Y. / Obi, S. / Chan, S. L. / Qin, S. / Kim, R. D. / Casey, M. et al. | 2015
- 2464
-
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancerMiddleton, G. / Crack, L. R. / Popat, S. / Swanton, C. / Hollingsworth, S. J. / Buller, R. / Walker, I. / Carr, T. H. / Wherton, D. / Billingham, L. J. et al. | 2015
- 2470
-
Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancerMichels, J. / Adam, J. / Goubar, A. / Obrist, F. / Damotte, D. / Robin, A. / Alifano, M. / Vitale, I. / Olaussen, K. A. / Girard, P. et al. | 2015
- 2477
-
Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancerTakeda, M. / Sakai, K. / Terashima, M. / Kaneda, H. / Hayashi, H. / Tanaka, K. / Okamoto, K. / Takahama, T. / Yoshida, T. / Iwasa, T. et al. | 2015
- 2483
-
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaNowak, A. K. / Cook, A. M. / McDonnell, A. M. / Millward, M. J. / Creaney, J. / Francis, R. J. / Hasani, A. / Segal, A. / Musk, A. W. / Turlach, B. A. et al. | 2015
- 2490
-
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institutionHosing, C. / Bassett, R. / Dabaja, B. / Talpur, R. / Alousi, A. / Ciurea, S. / Popat, U. / Qazilbash, M. / Shpall, E. J. / Oki, Y. et al. | 2015
- 2496
-
Alopecia in patients treated with molecularly targeted anticancer therapiesBelum, V. R. / Marulanda, K. / Ensslin, C. / Gorcey, L. / Parikh, T. / Wu, S. / Busam, K. J. / Gerber, P. A. / Lacouture, M. E. et al. | 2015
- 2503
-
Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancerSchirripa, M. / Loupakis, F. / Lonardi, S. / Cremolini, C. / Bergamo, F. / Zagonel, V. / Falcone, A. et al. | 2015
- 2504
-
Comment on ESMO Magnitude of Clinical Benefit ScaleMuhonen, T. / Joensuu, H. / Pfeiffer, P. et al. | 2015
- 2505
-
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)Gourgou-Bourgade, S. / Cameron, D. / Poortmans, P. / Asselain, B. / Azria, D. / Cardoso, F. / A'Hern, R. / Bliss, J. / Bogaerts, J. / Bonnefoi, H. et al. | 2015
- 2505
-
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancerO'Neil, B. H. / Scott, A. J. / Ma, W. W. / Cohen, S. J. / Leichman, L. / Aisner, D. L. / Menter, A. R. / Tejani, M. A. / Cho, J. K. / Granfortuna, J. et al. | 2015
- 2507
-
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsNieto, Y. / Tu, S. M. / Bassett, R. / Jones, R. B. / Gulbis, A. M. / Tannir, N. / Kingham, A. / Ledesma, C. / Margolin, K. / Holmberg, L. et al. | 2015